2017, Number 2
Waist-Length Index: Test for Cardiovascular Risk Assessment and Diagnosis of Metabolic Syndrome
Martínez MMLC, Blázquez GME, Hernández HME, López MP, Ortiz BAM, Kammar GA, Calderón IE, Delgado RJ, García CSP
Language: Spanish
References: 0
Page: 109-118
PDF size: 132.05 Kb.
ABSTRACT
Introduction: The presence of metabolic syndrome (MS) and cadiovascular disease (CVD) is physiopathologically linked to overweight and obesity.Objective: Evaluate the usefulness and accuracy of the waist-length index (CTI) in the assessment of risk and diagnosis of the metabolic syndrome and other cardiometabolic disorders.
Methods: Apparently healthy young adults were evaluated for their implementation as a diagnostic test or screening routine at the primary levels of health care. A cross-sectional study was conducted with a sample of 369 young adults aged 18-22 years of the first year of the medical degree at the Benemérita Autonomous University of Puebla (BUAP). Biochemical and anthropometric parameters were determined for the presence of metabolic syndrome and other cardiovascular alterations, the waist-height index was calculated and quartiles were generated to propose a cut-off point with which the risk and diagnostic utility could be assessed.
Results: The waist-height index showed to be a very sensitive (91%, 70% and 52%) and specific (78%, 78%, 76%) diagnostic test in the detection of metabolic syndrome, cardiovascular and atherogenic alterations, respectively. The predictive values showed 81% probability of having metabolic syndrome if the subject has a high waist-height index and 90% chance of not having metabolic syndrome if the waist-height index is normal.
Conclusions: The diagnostic accuracy of the waist-length index is very high, so it can be used as a diagnostic screen for metabolic syndrome or metabolic alterations in apparently healthy young adults.